DK1146041T3 - Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin - Google Patents

Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin

Info

Publication number
DK1146041T3
DK1146041T3 DK01400940T DK01400940T DK1146041T3 DK 1146041 T3 DK1146041 T3 DK 1146041T3 DK 01400940 T DK01400940 T DK 01400940T DK 01400940 T DK01400940 T DK 01400940T DK 1146041 T3 DK1146041 T3 DK 1146041T3
Authority
DK
Denmark
Prior art keywords
heterocycloalkylbenzocyclobutane
heteroarylbenzocyclobutane
noradrenaline
reuptake
serotonin
Prior art date
Application number
DK01400940T
Other languages
Danish (da)
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Bertrand Goument
Mark Millan
Francoise Lejeune
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1146041T3 publication Critical patent/DK1146041T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01400940T 2000-04-13 2001-04-12 Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin DK1146041T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0004742A FR2807753B1 (fr) 2000-04-13 2000-04-13 Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK1146041T3 true DK1146041T3 (da) 2004-03-22

Family

ID=8849212

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01400940T DK1146041T3 (da) 2000-04-13 2001-04-12 Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin

Country Status (25)

Country Link
US (1) US6420413B2 (de)
EP (1) EP1146041B1 (de)
JP (1) JP3761796B2 (de)
KR (1) KR100456795B1 (de)
CN (1) CN1166659C (de)
AR (1) AR028324A1 (de)
AT (1) ATE254102T1 (de)
AU (1) AU777825B2 (de)
BR (1) BR0101444A (de)
CA (1) CA2344255C (de)
DE (1) DE60101177T2 (de)
DK (1) DK1146041T3 (de)
EA (1) EA004473B1 (de)
ES (1) ES2210104T3 (de)
FR (1) FR2807753B1 (de)
HK (1) HK1042477B (de)
HU (1) HUP0101503A3 (de)
MX (1) MXPA01003553A (de)
NO (1) NO318158B1 (de)
NZ (1) NZ511092A (de)
PL (1) PL347056A1 (de)
PT (1) PT1146041E (de)
SI (1) SI1146041T1 (de)
TR (1) TR200302002T4 (de)
ZA (1) ZA200103065B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4897221B2 (ja) * 2002-12-20 2012-03-14 チバ ホールディング インコーポレーテッド アミン類の合成及びその合成のための中間体
US7803894B2 (en) * 2003-12-05 2010-09-28 3M Innovatie Properties Company Coating compositions with perfluoropolyetherisocyanate derived silane and alkoxysilanes
CN105541662B (zh) * 2015-12-28 2018-04-17 云南大学 二氢萘类化合物的固相合成方法
CN107445835B (zh) * 2017-07-05 2020-09-22 江苏师范大学 一种1,2-二氢环丁烯并[a]萘衍生物及其前体的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1738753E (pt) * 1993-06-28 2008-06-19 Wyeth Corp Novos tratamentos utilizando derivados de fenetilamina
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
EP0757687A1 (de) * 1994-04-23 1997-02-12 Smithkline Beecham Plc Tricyclische derivate als 5ht2c und 5ht2b antagonisten
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
FR2775687B1 (fr) * 1998-03-04 2000-04-14 Adir Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
SI1146041T1 (en) 2004-02-29
TR200302002T4 (tr) 2004-01-21
US6420413B2 (en) 2002-07-16
HK1042477A1 (en) 2002-08-16
FR2807753A1 (fr) 2001-10-19
PL347056A1 (en) 2001-10-22
EA200100343A2 (ru) 2001-10-22
EA200100343A3 (ru) 2002-02-28
NO20011862L (no) 2001-10-15
US20020019380A1 (en) 2002-02-14
MXPA01003553A (es) 2002-06-04
HK1042477B (zh) 2005-05-06
KR100456795B1 (ko) 2004-11-10
HUP0101503A3 (en) 2003-02-28
HUP0101503A2 (hu) 2002-05-29
HU0101503D0 (en) 2001-06-28
BR0101444A (pt) 2001-12-04
CN1323794A (zh) 2001-11-28
NZ511092A (en) 2002-10-25
EP1146041A1 (de) 2001-10-17
PT1146041E (pt) 2004-03-31
JP2001302599A (ja) 2001-10-31
ATE254102T1 (de) 2003-11-15
ZA200103065B (en) 2001-10-18
NO318158B1 (no) 2005-02-07
AU3518701A (en) 2001-10-18
EA004473B1 (ru) 2004-04-29
FR2807753B1 (fr) 2002-06-07
EP1146041B1 (de) 2003-11-12
CA2344255A1 (fr) 2001-10-13
KR20010098547A (ko) 2001-11-08
NO20011862D0 (no) 2001-04-11
DE60101177T2 (de) 2004-07-29
AU777825B2 (en) 2004-11-04
DE60101177D1 (de) 2003-12-18
CA2344255C (fr) 2006-07-11
AR028324A1 (es) 2003-05-07
JP3761796B2 (ja) 2006-03-29
CN1166659C (zh) 2004-09-15
ES2210104T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
CY2014022I1 (el) Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης
NO20034307L (no) Cyklopropylindol-derivater som selektive serotonin- gjenopptaksinhibitorer
DK1638933T3 (da) N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer
DK1480962T3 (da) 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer
NO20026010L (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK1339679T3 (da) 3-Aroylindolderivater og deres anvendelse som agonister af CB2-receptorer
DK1931645T3 (da) N-(3-aminoquinoxalin-2-yl)-sulfonamidderivater og deres anvendelse som inhibitorer af phosphatidylinositol-3-kinase
DK1252144T3 (da) Substituerede glutarimider og deres anvendelse som inhibitorer af IL-12-produktionen
DK2332909T3 (da) Hydroxybenzamidderivater og deres anvendelse som inhibitorer af hsp90
DK1562589T3 (da) Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser
DK1212320T3 (da) Phenylpiperazinderivater som inhibitorer for genoptag af serotonin
NO20030842L (no) Fenoksybenzylaminderivater som selektive serotonin- gjenopptaksinhibitorer
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
DK1651644T3 (da) Substituerede derivater af thiazol-benzoisothiazoldioxid, fremgangsmåde deraf og deres anvendelse
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
DK1636228T3 (da) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
DK1438289T3 (da) Indolderivater som cox II-inhibitorer
DK1643985T3 (da) Kombinationen af en serotonin-genoptagelseshæmmer og agomelatin
NO20034525L (no) Fenylheterocyklyleterderivater med serotonin re- opptaksinhibitorer
DK1146041T3 (da) Derivater af heterocycloalkylbenzocyclobutan og heteroarylbenzocyclobutan og deres anvendelse som inhibitorer for genoptagelse af serotonin og noradrenalin
NO20030813D0 (no) Bifenylderivater og deres anvendelse som integrininhibitorer
DK1299365T3 (da) 2-aminothiazolinderivater og deres anvendelse som inhibitorer for NO-synthase
NO20032248L (no) Ny anvendelse av kombinerte 5-HT1A-agonister og selektive inhibitorer for serotoningjenopptaksinhibitorer
DK1908760T3 (da) Chroman- og thiochroman-3-yl-1,3-dihydroimidazoler som inhibitorer af dopamin-beta-hydroxylase og fremgangsmåder til deres fremstilling
DK1682523T3 (da) Morpholin-derivater som noradrenalin-genoptagelsesinhibitorer